- REPORT SUMMARY
- TABLE OF CONTENTS
-
Calcium channel blockers?CCBs? are medications which are used control high blood pressure, chest pain and arrhythmia. They are available through prescription and work by relaxing blood vessels and increase the blood and oxygen supply to the heart. This reduces the workload of the heart. It can be prescribed by itself or in combination with other medications to treat high blood pressure and angina. There are a few different types of CCB and each works in a slightly different way.
The report details the trend, potential and market size of Calcium Channel Blocker market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Calcium Channel Blockermarket, defines the market attractiveness level of Calcium Channel Blocker market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Calcium Channel Blocker industry, describes the types of Calcium Channel Blocker market, the applications of major players and the market size, and deeply analyzes the current situation of the global Calcium Channel Blocker market and the development prospects and opportunities of Calcium Channel Blocker industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Calcium Channel Blocker market in Chapter 13.
By Player:
Novartis
AstraZeneca
Knoll Pharmaceuticals
Bayer
Pfizer
Sanofi
Wyeth-Ayerst
Pfizer
AstraZeneca
Searle
By Type:
Dihydropyridine
Diltiazem
Verapamil
Others
By End-User:
Hypertension
Coronary Artery Disease
Arrhythmia
Cardiomyopathy
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Calcium Channel Blocker Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Calcium Channel Blocker Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Calcium Channel Blocker Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Calcium Channel Blocker Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Calcium Channel Blocker Market Analysis and Outlook to 2022
-
7.1 Global Calcium Channel Blocker Consumption (2017-2022)
-
7.2 United States Calcium Channel Blocker Consumption (2017-2022)
-
7.3 Europe Calcium Channel Blocker Consumption (2017-2022)
-
7.4 China Calcium Channel Blocker Consumption (2017-2022)
-
7.5 Japan Calcium Channel Blocker Consumption (2017-2022)
-
7.6 India Calcium Channel Blocker Consumption (2017-2022)
-
7.7 South Korea Calcium Channel Blocker Consumption (2017-2022)
8 Region and Country-wise Calcium Channel Blocker Market Analysis and Outlook to 2028
-
8.1 Global Calcium Channel Blocker Consumption Forecast (2022-2028)
-
8.2 United States Calcium Channel Blocker Consumption Forecast (2022-2028)
-
8.3 Europe Calcium Channel Blocker Consumption Forecast (2022-2028)
-
8.4 China Calcium Channel Blocker Consumption Forecast (2022-2028)
-
8.5 Japan Calcium Channel Blocker Consumption Forecast (2022-2028)
-
8.6 India Calcium Channel Blocker Consumption Forecast (2022-2028)
-
8.7 South Korea Calcium Channel Blocker Consumption Forecast (2022-2028)
9 Global Calcium Channel Blocker Market Outlook by Types and Applications to 2022
-
9.1 Global Calcium Channel Blocker Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Dihydropyridine Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Diltiazem Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Verapamil Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Calcium Channel Blocker Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hypertension Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Coronary Artery Disease Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Arrhythmia Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Cardiomyopathy Consumption and Growth Rate (2017-2022)
10 Global Calcium Channel Blocker Market Outlook by Types and Applications to 2028
-
10.1 Global Calcium Channel Blocker Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Dihydropyridine Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Diltiazem Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Verapamil Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Calcium Channel Blocker Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Coronary Artery Disease Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Arrhythmia Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Cardiomyopathy Consumption Forecast and Growth Rate (2022-2028)
11 Global Calcium Channel Blocker Import and Export Analysis (Top 5 Countries)
-
11.1 Global Calcium Channel Blocker Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Calcium Channel Blocker Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Calcium Channel Blocker Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Calcium Channel Blocker Market Competitive Analysis
-
14.1 Novartis
-
14.1.1 Novartis Company Details
-
14.1.2 Novartis Calcium Channel Blocker Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Novartis Calcium Channel Blocker Product and Service
-
14.2 AstraZeneca
-
14.2.1 AstraZeneca Company Details
-
14.2.2 AstraZeneca Calcium Channel Blocker Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 AstraZeneca Calcium Channel Blocker Product and Service
-
14.3 Knoll Pharmaceuticals
-
14.3.1 Knoll Pharmaceuticals Company Details
-
14.3.2 Knoll Pharmaceuticals Calcium Channel Blocker Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Knoll Pharmaceuticals Calcium Channel Blocker Product and Service
-
14.4 Bayer
-
14.4.1 Bayer Company Details
-
14.4.2 Bayer Calcium Channel Blocker Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bayer Calcium Channel Blocker Product and Service
-
14.5 Pfizer
-
14.5.1 Pfizer Company Details
-
14.5.2 Pfizer Calcium Channel Blocker Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Pfizer Calcium Channel Blocker Product and Service
-
14.6 Sanofi
-
14.6.1 Sanofi Company Details
-
14.6.2 Sanofi Calcium Channel Blocker Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Sanofi Calcium Channel Blocker Product and Service
-
14.7 Wyeth-Ayerst
-
14.7.1 Wyeth-Ayerst Company Details
-
14.7.2 Wyeth-Ayerst Calcium Channel Blocker Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Wyeth-Ayerst Calcium Channel Blocker Product and Service
-
14.8 Pfizer
-
14.8.1 Pfizer Company Details
-
14.8.2 Pfizer Calcium Channel Blocker Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Pfizer Calcium Channel Blocker Product and Service
-
14.9 AstraZeneca
-
14.9.1 AstraZeneca Company Details
-
14.9.2 AstraZeneca Calcium Channel Blocker Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 AstraZeneca Calcium Channel Blocker Product and Service
-
14.10 Searle
-
14.10.1 Searle Company Details
-
14.10.2 Searle Calcium Channel Blocker Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Searle Calcium Channel Blocker Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Calcium Channel Blocker
-
Figure Calcium Channel Blocker Picture
-
Table Global Calcium Channel Blocker Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Calcium Channel Blocker Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Calcium Channel Blocker Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Calcium Channel Blocker Consumption by Country (2017-2022)
-
Figure United States Calcium Channel Blocker Consumption and Growth Rate (2017-2022)
-
Table Europe Calcium Channel Blocker Consumption and Growth Rate (2017-2022)
-
Figure China Calcium Channel Blocker Consumption and Growth Rate (2017-2022)
-
Figure Japan Calcium Channel Blocker Consumption and Growth Rate (2017-2022)
-
Figure India Calcium Channel Blocker Consumption and Growth Rate (2017-2022)
-
Figure South Korea Calcium Channel Blocker Consumption and Growth Rate (2017-2022)
-
Figure Global Calcium Channel Blocker Consumption Forecast by Country (2022-2028)
-
Figure United States Calcium Channel Blocker Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Calcium Channel Blocker Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Calcium Channel Blocker Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Calcium Channel Blocker Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Calcium Channel Blocker Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Calcium Channel Blocker Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Dihydropyridine Consumption and Growth Rate (2017-2022)
-
Figure Global Diltiazem Consumption and Growth Rate (2017-2022)
-
Figure Global Verapamil Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Hypertension Consumption and Growth Rate (2017-2022)
-
Figure Global Coronary Artery Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Arrhythmia Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiomyopathy Consumption and Growth Rate (2017-2022)
-
Figure Global Dihydropyridine Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diltiazem Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Verapamil Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hypertension Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Coronary Artery Disease Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Arrhythmia Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiomyopathy Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Calcium Channel Blocker Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Calcium Channel Blocker Export by Region (Top 5 Countries) (2017-2028)
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Calcium Channel Blocker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Calcium Channel Blocker Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Calcium Channel Blocker Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Calcium Channel Blocker Product and Service
-
Table Knoll Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Knoll Pharmaceuticals Calcium Channel Blocker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Knoll Pharmaceuticals Calcium Channel Blocker Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Calcium Channel Blocker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Calcium Channel Blocker Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Calcium Channel Blocker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Calcium Channel Blocker Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Calcium Channel Blocker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Calcium Channel Blocker Product and Service
-
Table Wyeth-Ayerst (Foundation Year, Company Profile and etc.)
-
Table Wyeth-Ayerst Calcium Channel Blocker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Wyeth-Ayerst Calcium Channel Blocker Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Calcium Channel Blocker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Calcium Channel Blocker Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Calcium Channel Blocker Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Calcium Channel Blocker Product and Service
-
Table Searle (Foundation Year, Company Profile and etc.)
-
Table Searle Calcium Channel Blocker Sales, Price, Value and Gross Profit (2017-2022)
-
Table Searle Calcium Channel Blocker Product and Service
-